J.W. Cole Advisors, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

J.W. Cole Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 10, 2022	BUY	$0.5 - $1.06 $5,376 - $11,397	10,752 New	10,752 $9,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $5,376 - $11,397	-10,752 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$0.96 - $1.74 $10,321 - $18,708	10,752 New	10,752 $11,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.